Gefapixant Citrate is a selective P2X3 receptor antagonist indicated for the treatment of refractory or unexplained chronic cough in adults. By modulating sensory nerve pathways involved in the cough reflex,… Read more
Gefapixant Citrate is a selective P2X3 receptor antagonist indicated for the treatment of refractory or unexplained chronic cough in adults. By modulating sensory nerve pathways involved in the cough reflex, this antitussive agent represents a targeted therapeutic approach to managing persistent cough symptoms. Pharmaceutical laboratories rely on a comprehensive range of high-quality reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds, to support the analytical characterization of this substance. These materials are critical for accurate impurity profiling, method validation, and routine quality control during drug development and manufacturing processes. Chemists utilize these reference materials to ensure the precision of assay methods and to maintain the integrity of pharmaceutical products throughout the regulatory lifecycle. By providing essential tools for the identification and quantification of impurities, these compounds facilitate adherence to stringent quality standards within the pharmaceutical industry.